CIK 0001396814
- Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 510619477
- Phone
- +1 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $217,920
- in 1 filing, $218K under 10b5-1 plans
Net −$217,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-18 | Williams Kristen Marie Chief Administrative Officer | Option exercise · Stock Option (Right to Buy) | −1,375 | 0 | ||
| 2022-01-18 | Williams Kristen Marie Chief Administrative Officer | Option exercise · Stock Option (Right to Buy) | −2,600 | 12,165 | ||
| 2022-01-18 | Williams Kristen Marie Chief Administrative Officer | Option exercise · Stock Option (Right to Buy) | −6,338 | 12,672 | ||
| 2022-01-18 | Williams Kristen Marie Chief Administrative Officer | Option exercise · Stock Option (Right to Buy) | −13,127 | 21,873 | ||
| 2022-01-18 | Riker Lauren Bullaro Senior Vice President, Finance | Option exercise | +2,500 | $10.81 | $27K | 17,652 |
| 2022-01-18 | Riker Lauren Bullaro Senior Vice President, Finance | Sale | −2,500 | $64.97 | $162K | 15,152 |
| 2022-01-18 | Riker Lauren Bullaro Senior Vice President, Finance | Option exercise · Stock Option (Right to Buy) | −2,500 | 9,300 | ||
| 2022-01-18 | MOLLOY ANTHONY Chief Lgl & Compliance Officer | Sale | −224 | $63.55 | $14K | 17,550 |
| 2022-01-11 | STACK DAVID M CEO and Chairman | Option exercise | +15,000 | $10.81 | $162K | 109,374 |
| 2022-01-11 | STACK DAVID M CEO and Chairman | Option exercise · Stock Option (Right to Buy) | −15,000 | 58,670 | ||
| 2022-01-04 | Riker Lauren Bullaro Senior Vice President, Finance | Grant or award | +2,000 | 15,152 | ||
| 2022-01-04 | Riker Lauren Bullaro Senior Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2022-01-04 | MOLLOY ANTHONY Chief Lgl & Compliance Officer | Grant or award | +2,000 | 17,774 | ||
| 2022-01-04 | MOLLOY ANTHONY Chief Lgl & Compliance Officer | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2021-12-17 | Froimson Mark Director | Gift | −400 | 5,908 | ||
| 2021-11-22 | LARANJEIRA CHARLES ANTHONY Chief Technical Officer | Option exercise | +7,500 | $44.10 | $331K | 33,602 |
| 2021-11-22 | LARANJEIRA CHARLES ANTHONY Chief Technical Officer | Option exercise · Stock Option (Right to Buy) | −7,500 | 0 | ||
| 2021-11-16 | STACK DAVID M CEO and Chairman | Option exercise | +15,000 | $10.81 | $162K | 94,085 |
| 2021-11-16 | STACK DAVID M CEO and Chairman | Option exercise · Stock Option (Right to Buy) | −15,000 | 73,670 | ||
| 2021-11-04 | WINSTON ROY Chief Medical Officer | Option exercise | +10,000 | $48.15 | $482K | 46,456 |
Page 21 of 23 · 450 trades